Derek A. Cogan

2.6k total citations · 1 hit paper
17 papers, 2.1k citations indexed

About

Derek A. Cogan is a scholar working on Organic Chemistry, Molecular Biology and Inorganic Chemistry. According to data from OpenAlex, Derek A. Cogan has authored 17 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Organic Chemistry, 7 papers in Molecular Biology and 6 papers in Inorganic Chemistry. Recurrent topics in Derek A. Cogan's work include Asymmetric Hydrogenation and Catalysis (5 papers), Asymmetric Synthesis and Catalysis (4 papers) and Synthesis and Catalytic Reactions (3 papers). Derek A. Cogan is often cited by papers focused on Asymmetric Hydrogenation and Catalysis (5 papers), Asymmetric Synthesis and Catalysis (4 papers) and Synthesis and Catalytic Reactions (3 papers). Derek A. Cogan collaborates with scholars based in United States, France and Japan. Derek A. Cogan's co-authors include Jonathan A. Ellman, Guangcheng Liu, Guangcheng Liu, Tony P. Tang, Bradley J. Backes, Kyung‐Jin Kim, Zhongmin Xu, Amir H. Hoveyda, Ahmad Houri and George Borg and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Derek A. Cogan

17 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Catalytic Asymmetric Synthesis of tert-Butanesulfinamide. Application to the Asymmetric Synthesis of Amines

1997 419 citations Guangcheng Liu, Derek A. Cogan et al. Journal of the American Chemical Society profile →

Peers

Countries citing papers authored by Derek A. Cogan

Since Specialization

Citations

This map shows the geographic impact of Derek A. Cogan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Derek A. Cogan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Derek A. Cogan more than expected).

Fields of papers citing papers by Derek A. Cogan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Derek A. Cogan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Derek A. Cogan. The network helps show where Derek A. Cogan may publish in the future.

Co-authorship network of co-authors of Derek A. Cogan

This figure shows the co-authorship network connecting the top 25 collaborators of Derek A. Cogan. A scholar is included among the top collaborators of Derek A. Cogan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Derek A. Cogan. Derek A. Cogan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Pharmacodynamic effects of highly selective aldosterone synthase inhibitor vicadrostat in cynomolgus monkeys: Contrasting effects of once versus twice daily dosing 2025 ·Journal of Pharmacology and Experimental Therapeutics ·Steven M. Weldon, Derek A. Cogan, Matthew A. Cerny, Kosea S. Frederick, (unknown), (unknown), Stanley Kugler, Daniel R. Marshall, Jeremy G. Richman, N Brown	1
2	Abstract 517: Targeting chromosomally unstable tumors with a selective KIF18A inhibitor 2023 ·Cancer Research ·(unknown), Rumin Zhang, Akanksha Verma, Tamar Y. Feinberg, (unknown), (unknown), (unknown), Sarah E. Bettigole, (unknown), Scott Drutman, Michael Su, Derek A. Cogan, Christina H. Eng	1
3	Discovery of potent, orally active KIF18A inhibitors targeting CIN-high cancer cells. 2022 ·Journal of Clinical Oncology ·Rumin Zhang, Derek A. Cogan, (unknown), (unknown), (unknown), Tamar Y. Feinberg, Akanksha Verma, Richard W. Tourdot, Albert Swiston, Sarah E. Bettigole, Scott Drutman, Michael Su	2
4	Selectivity of BI 689648, a Novel, Highly Selective Aldosterone Synthase Inhibitor: Comparison with FAD286 and LCI699 in Nonhuman Primates 2016 ·Journal of Pharmacology and Experimental Therapeutics ·Steven M. Weldon, Matthew A. Cerny, (unknown), Derek A. Cogan, Xin Guo, Neil Moss, (unknown), (unknown), Gregory A. Reinhart, Nicholas F. Brown	23
5	Exploration of cathepsin S inhibitors characterized by a triazole P1–P2 amide replacement 2012 ·Bioorganic & Medicinal Chemistry Letters ·Neil Moss, Zhaoming Xiong, (unknown), Derek A. Cogan, (unknown), (unknown), (unknown), Eugene R. Hickey, Raj Nagaraja, Matthew R. Netherton, (unknown), (unknown), (unknown), Daw-Tsun Shih, Yancey D. Ward, Erick R. R. Young, Qing Zhang	11
6	Indole RSK inhibitors. Part 1: Discovery and initial SAR 2011 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Jennifer Burke, Xin Guo, (unknown), Roger J. Snow, Yunlong Zhang, (unknown), (unknown), Alan Swinamer, John K. Westbrook, (unknown), Anil K. Padyana, Derek A. Cogan, (unknown), Zhaoming Xiong, Jeffrey B. Madwed, Mohammed A. Kashem, Stanley Kugler, (unknown)	25
7	A new class of 5-HT2B antagonists possesses favorable potency, selectivity, and rat pharmacokinetic properties 2009 ·Bioorganic & Medicinal Chemistry Letters ·Neil Moss, Younggi Choi, Derek A. Cogan, Adam Flegg, (unknown), (unknown), (unknown), Raj Nagaraja, (unknown), (unknown), Janet T. Peterson, (unknown), Christopher R. Sarko, Donna Skow, (unknown), Heather Tye, (unknown)	22
8	Synthesis and SAR studies of indole-based MK2 inhibitors 2008 ·Bioorganic & Medicinal Chemistry Letters ·Zhaoming Xiong, (unknown), Derek A. Cogan, Daniel R. Goldberg, Ming‐Hong Hao, Neil Moss, Edward J. Pack, (unknown), Donna Skow, Thomas Trieselmann, Brian Werneburg, André White	32
9	Structure-based design and subsequent optimization of 2-tolyl-(1,2,3-triazol-1-yl-4-carboxamide) inhibitors of p38 MAP kinase 2008 ·Bioorganic & Medicinal Chemistry Letters ·Derek A. Cogan, (unknown), Eric C. Breinlinger, (unknown), Daniel R. Goldberg, (unknown), (unknown), Neil Moss, Christopher Pargellis, Kevin Qian, Alan Swinamer	21
10	One-pot asymmetric synthesis of tert-butanesulfinyl-protected amines from ketones by the in situ reduction of tert-butanesulfinyl ketimines 1999 ·Tetrahedron Letters ·George Borg, Derek A. Cogan, Jonathan A. Ellman	90
11	Asymmetric synthesis of chiral amines by highly diastereoselective 1,2-additions of organometallic reagents to N-tert-butanesulfinyl imines 1999 ·Tetrahedron ·Derek A. Cogan, Guangcheng Liu, Jonathan A. Ellman	286
12	Synthesis of Enantiomerically Pure N-tert-Butanesulfinyl Imines (tert-Butanesulfinimines) by the Direct Condensation of tert-Butanesulfinamide with Aldehydes and Ketones 1999 ·The Journal of Organic Chemistry ·Guangcheng Liu, Derek A. Cogan, (unknown), Tony P. Tang, Jonathan A. Ellman	439
13	Asymmetric Synthesis of α,α-Dibranched Amines by the Trimethylaluminum-Mediated 1,2-Addition of Organolithiums to tert-Butanesulfinyl Ketimines 1998 ·Journal of the American Chemical Society ·Derek A. Cogan, Jonathan A. Ellman	200
14	Catalytic Asymmetric Oxidation oftert-Butyl Disulfide. Synthesis oftert-Butanesulfinamides,tert-Butyl Sulfoxides, andtert-Butanesulfinimines 1998 ·Journal of the American Chemical Society ·Derek A. Cogan, Guangcheng Liu, Kyung‐Jin Kim, Bradley J. Backes, Jonathan A. Ellman	304
15	Catalytic Asymmetric Synthesis of tert-Butanesulfinamide. Application to the Asymmetric Synthesis of Amines breakdown → 1997 ·Journal of the American Chemical Society ·Guangcheng Liu, Derek A. Cogan, Jonathan A. Ellman	419
16	Applications of Zr-Catalyzed Carbomagnesation and Mo-Catalyzed Macrocyclic Ring Closing Metathesis in Asymmetric Synthesis. Enantioselective Total Synthesis of Sch 38516 (Fluvirucin B₁) 1997 ·Journal of the American Chemical Society ·Zhongmin Xu, Charles W. Johannes, Ahmad Houri, Daniel S. La, Derek A. Cogan, (unknown), Amir H. Hoveyda	90
17	Cascade Catalysis in Synthesis. An Enantioselective Route to Sch 38516 (and Fluvirucin B1) Aglycon Macrolactam 1995 ·Journal of the American Chemical Society ·Ahmad Houri, Zhongmin Xu, Derek A. Cogan, Amir H. Hoveyda	125

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact